ESTRO Vision 2030.
"Radiation Oncology. Optimal Health for all, together."
If, by 2035, every cancer patient who needs radiotherapy has access to it, almost one million more lives will be saved every year worldwide.
ESTRO has over 7600 members - professionals of radio oncology and beyond, in over 100 countries.
ESTRO 2020 becomes a fully online congress.
Consult our FAQs on the event's pages
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study - Read It
Randomised Phase II Trial of Nivolumab with Stereotactic Body Radiotherapy versus Nivolumab alone in Metastatic Head and Neck Squamous Cell Carcinoma _ Read It
EMUC20 is now a Virtual Meeting! - Conferences Corner
Serbian Society of Radiotherapy Technicians - 10 years of professional improvement - RTT Corner
ESTRO TTG Report Impact of carbon radiation versus photon radiation on immunotherapy
The power of migration - Young Corner
Constant improvement in quality and safety of radiology, radiotherapy and nuclear medicine through clinical audit: the QUADRANT project - Research Corner